8 results match your criteria: "UFR de UMR Université-INRA d'Immunologie Parasitaire[Affiliation]"

Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninum.

Int J Parasitol

May 2011

Université François-Rabelais de Tours, INRA, UMR 0483 Université-INRA d'Immunologie Parasitaire, Vaccinologie et Biothérapie Anti-Infectieuse, IFR des Agents Transmissibles et Infectiologie, UFR de Pharmacie, Tours, France.

Neospora caninum is an intracellular protozoan pathogen that causes abortion in cattle. We studied how the interaction between murine conventional dendritic cells or macrophages and N. caninum influences the generation of cell-mediated immunity against the parasite.

View Article and Find Full Text PDF

Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep.

Vet Res

September 2010

Université François Rabelais, INRA, UMR 0483 Université-INRA d'Immunologie Parasitaire, Vaccinologie et Biothérapie Anti-infectieuse, IFR136 Agents Transmissibles et Infectiologie, UFR de Pharmacie, 31 avenue Monge, 37200 Tours, France.

This study assessed the effectiveness of a mutant strain of Toxoplasma gondii (RH strain) lacking the mic1 and mic3 genes (Mic1-3KO) against Toxoplasma abortion in sheep. Ewes were inoculated subcutaneously with 10(5) Mic1-3KO tachyzoïtes in three independent experiments. Following vaccination, Mic1-3KO induced a mild febrile response and serum IgG antibodies, which persisted throughout the experiments.

View Article and Find Full Text PDF

Mic1-3KO tachyzoite a live attenuated vaccine candidate against toxoplasmosis derived from a type I strain shows features of type II strain.

Exp Parasitol

October 2009

Université François Rabelais de Tours, INRA UMR Université-INRA d'Immunologie Parasitaire et Vaccinologie, Biothérapie anti-infectieuse, IFR agents transmissibles et infectiologie, UFR de Pharmacie, Parc Grandmont, Tours, France.

Vaccination with live attenuated parasites has been shown to induce high level of protection against Toxoplasma gondii. In this study we compared the Mic1-3KO tachyzoite (a live attenuated strain) with the parental wild type (WT) tachyzoite in terms of virulence in mice in vivo, dissemination in mouse tissues and persistence in mouse brain. Survival of mice infected with the Mic1-3KO parasites correlated with reduced parasite burden in mouse tissues compared to the parental strain.

View Article and Find Full Text PDF

Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.

Vaccine

March 2006

Université François-Rabelais de Tours, INRA, UMR 0483 Université-INRA d'Immunologie Parasitaire et de Vaccinologie, IFR Agents Transmissibles et Infectiologie, UFR des Sciences Pharmaceutiques, 31 Avenue Monge, 37200 Tours, France.

Toxoplasma gondii enters the mucosal surfaces of the host, and so immunity at these sites is of major interest. Due to the compartmentalization of the immune response, systemic immunization does not induce high levels of immunity at mucosal surfaces. Intranasal immunization has been shown to be very effective in inducing both systemic and mucosal immune responses.

View Article and Find Full Text PDF

Cambodia is located in an area of resistance to multiple antimalarials and has been the first country to implement the systematic use of an artesunate-mefloquine combination as first-line treatment for Plasmodium falciparum malaria. Little is known, however, about the prevalence of resistance mutations within the natural parasite populations, impeding rational drug policy in this context. Using direct sequencing of PCR products, we have analyzed sequence polymorphism of the dihydrofolate reductase-thymidylate synthase, dihydropteroate synthetase, and multidrug resistance 1 genes in a large number of clinical P.

View Article and Find Full Text PDF

To develop a multiantigenic vaccine against toxoplasmosis, two Toxoplasma gondii antigens, SAG1 and GRA4 selected on the basis of previous immunological and immunization studies, were chosen. We showed that DNA-based immunization with plasmids expressing GRA4 (pGRA4) or SAG1 (pSAG1mut) reduced mortality of susceptible C57BL/6 mice upon oral challenge with cysts of the 76K type II strain (62% survival). Immunization with pGRA4 and pSAG1mut, enhanced the protection (75% survival).

View Article and Find Full Text PDF

Prospects for a human Toxoplasma vaccine.

Curr Drug Targets Immune Endocr Metabol Disord

October 2002

UFR de UMR Université-INRA d'Immunologie Parasitaire, Pharmacie Tours, 31 Av. Monge, F-37200 Tours, France.

Human toxoplasmosis is usually benign, but may occasionally lead to severe or lethal damages when combined with immunosuppressive states or when transmitted to the fetus during pregnancy. Only a vaccine could prevent these harmful effects. The oral route is the natural portal of entry of T.

View Article and Find Full Text PDF

Toxoplasma gondii is an obligate intracellular parasite that infects a wide variety of nucleated cells in its numerous intermediate hosts, including humans. Much interest has focused on the ability of gamma interferon (IFN-gamma)-activated macrophages to prevent intracellular replication, but some other cells (e.g.

View Article and Find Full Text PDF